European Medicines Agency Related News
First CBD oil to be approved by the European Medicines Agency
A GW Pharmaceuticals Cannabidiol oral solution, EPIDYOLEX®, is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA).
EPIDYOLEX® cannabidiol oral...
Pharmacovigilance in the EU: a closer look at EudraVigilance
Health Europa highlights the role of EudraVigilance in the pharmacovigilance activities of the EMA, from the launch of the revamped system in 2017 to...
CAR T-cell therapies in Europe
Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union.
In June, the European Medicines...
Safeguarding the availability of medicines in the EU
In its newly published work programme for 2019/20, an EU-wide task force has set out a series of necessary actions to ensure the availability...
UK nursing union calls for second Brexit referendum
The UK’s Royal College of Nursing has written to the leaders of nine of the UK’s political parties, calling for a second Brexit referendum.
In...
EMA responds to liver injury concerns over uterine fibroids medicine
The European Medicines Agency (EMA) has responded to concerns that Esmya (ulipristal acetate), a uterine fibroids medicine, presents a risk of serious liver injury.
Having...
The potential of advanced therapy medicinal products in Europe
Together, the European Commission and the European Medicines Agency are working to bring game-changing advanced therapy medicinal products to the patients who need them.
So-called...
European Medicines Agency prepares pharmaceutical companies for Brexit
The European Medicines Agency (EMA) and the European Commission have updated their guidance which will help pharmaceutical companies prepare for the UK’s withdrawal from...
Three new medicines recommended for approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) have recommended three new medicines for approval that will treat numerous...